Angiotensin i converting enzyme inhibitor and angiotensin Ii antagonist
Kono, T.; Ikeda, F.; Oseko, F.; Imura, H.; Endo, J.
Nihon Rinsho. Japanese Journal of Clinical Medicine 36(11): 3613-3620
1978
ISSN/ISBN: 0047-1852 PMID: 215799 Document Number: 138928
Document emailed within 1 workday
Related Documents
Iimura, O.; Kusano, E.; Tanba, K.; Yanagiba, S.; Amemiya, M.; Ando, Y.; Honma, S.; Muto, S.; Asano, Y. 2003: Additive antiproteinuric effect of angiotensin Ii receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis Nihon Jinzo Gakkai Shi 45(5): 439-444Zhang, R.-y.; Huang, Y.-l.; Sun, Y.-h. 2005: Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase Zhonghua Yi Xue Za Zhi 85(15): 1053-1056
Philips, J.C.; Weekers, L.; Scheen, A.J. 2001: Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy Revue Medicale de Liege 56(2): 126-128
Anantharaman, R.; Bhansali, A.; Bhadada, S.K.; Kohli, H.S.; Dutta, P.; Walia, R.; Jayaprakash, P.; Upreti, V. 2010: Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor and angiotensin receptor blocker in type 1 DM with nephropathy Indian Journal of Medical Research 132: 42-47
Diskin, C.J.; Stokes, T.J.; Dansby, L.M.; Radcliff, L.; Carter, T.B. 2007: Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker? Journal of Nephrology 20(4): 410-416
Antelava, N.A.; Gongadze, N.V.; Gogolauri, M.I.; Kezeli, T.D.; Pachkoriia, K.Z. 2007: Comparative characteristic of angiotensin-converting enzyme inhibitor--captopril and the angiotensin Ii receptor blokers--losartan action on the oxidative metabolism in experimental hyperlipidemia in rabbits Georgian Medical News 150: 57-60
Zapesochnaia, I.L.; Avtandilov, A.G. 2014: The influence of combined therapy with calcium antagonist and angiotensin-converting enzyme inhibitor on the circadian profile of arterial pressure in patients with arterial hypertension in the Far North Klinicheskaia Meditsina 92(10): 33-40
Haghfelt, T. 1994: Trandolapril--a new angiotensin-converting enzyme inhibitor Ugeskrift for Laeger 156(42): 6232-6235
Papadopoulos, D.P.; Economou, E.V.; Makris, T.K.; Kapetanios, K.J.; Moyssakis, I.; Votteas, V.E.; Toutouzas, P.K. 2004: Effect of angiotensin-converting enzyme inhibitor on collagenolytic enzyme activity in patients with acute myocardial infarction Drugs under Experimental and Clinical Research 30(2): 55-65
Dzau, V.I. 1989: Quinapril--a new angiotensin-converting enzyme inhibitor: an overview Angiology 40(4 Pt 2): 329-330
Bajaj, A.K. 1988: Enalapril: a second-generation angiotensin converting enzyme inhibitor American Journal of the Medical Sciences 296(5): 332-335
Smet, B.S.; De Kock, I.; De Backer, A.I.; Verstraete, K. 2013: Angioedema of the small bowel caused by angiotensin converting enzyme inhibitor JBR-BTR: Organe de la Societe Royale Belge de Radiologie 96(1): 41
Yanturali, S.; Ergun, N.; Eminoglu, O.; Kalkan, S.; Tuncok, Y. 2004: Life threatening tongue angioedema associated with an angiotensin-converting enzyme inhibitor Veterinary and Human Toxicology 46(2): 85-86
Zagidullin, N.S.; Valeeva, K.F.; Zagidullin, S.Z.; Rezbaeva, A.G. 2010: Possibilities of the use Angiotensin converting enzyme inhibitor in peripheral arterial disease Kardiologiia 50(4): 92-96
Ryan, M.J.; Boucher, D.M.; Cohen, D.M.; Essenburg, A.D.; Major, T.C.; Mertz, T.E.; Olszewski, B.J.; Randolph, A.E.; Singer, R.M.; Kaplan, H.R. 1984: Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitor Journal of Pharmacology and Experimental Therapeutics 228(2): 312-318
Bakris, G.L.; Weir, M.R. 2000: Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern? Archives of Internal Medicine 160(5): 685-693
Fagard, R.; Amery, A.; Lijnen, P.; Staessen, J. 1980: First dose effect of the oral angiotensin converting enzyme inhibitor captopril Archives Internationales de Pharmacodynamie et de Therapie Suppl: 178-187
Ganten, D.; Mullins, J.; Lindpaintner, K. 1989: The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors Journal of Human Hypertension 3(Suppl 1): 63-70
Aurell, M. 1984: Physiological aspects of the renin-angiotensin system and peroral angiotensin converting enzyme inhibition Scandinavian Journal of Urology and Nephrology. Supplementum 79: 9-12
De Paz, S.; Martín, A.B.; Iglesias, A.; Domínguez, A.R. 1999: Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin Ii receptor antagonists Medicina Clinica 113(19): 759